PYC

0.00%

10.5¢ pyc therapeutics limited

PYC turns 2 corners, page-3

First 3 Last

Share
Profile

Follow
rogues

1,659 Posts.

1113

16/05/23

02:52

Post #: 67788521
Share
Originally posted by Medicine Man: ↑

@travelbug2 let's hope we have turned the corner and those 2 brokers would stop their price control.

The future income derived from the 3 drugs already announced would be $1b + $2b + $3b = $6b US Dollars (A$8.6b) for treating RP-11, ADOA, and for Phelan-McDermid Syndrome respectively.

For biotech shares in the US, the P/E ratio is 17 on average. Let's apply a P/E of 10 just to be conservative in Australia until PYC is listed in the US Market. The market cap would be at least A$86b. That would make it rank 4th in the ASX50 behind CSL. Sure it would take 2, 3 or 5 years to reach that target. In the mean time, if another Kidney or CNS drug is added to the pipeline with US5b annual income, market cap would swell to A$157b in a couple more years, ranking 3rd ahead of CSL.

Now you would see the enormous potential of this share and it could be the reason for brokers to stagnate the SP regardless of major milestones being met and quite possibly even after patients are being dosed. They just want to slowly accumulate shares at a bargain basement price of 6c.This cycle could not be broken without the following steps:
Educate existing and prospective brokers/shareholders about the enormous potential in PYC's income stream.
Solid news such as successful readouts from clinical trials which would cause a quantum leap in SP.
Other brokers to use an exact opposite tactic to defeat those 2 by buying shares slowly and consistently.
Preferably all of the above and have Step 3 maintained even after solid news to stop the SP drifting back down artificially.

I am determined to make Rohan aware of our frustration on the seemingly controlled SP and the needs to do more Road Shows to educate many more brokers.

Expand

Thank you for the thought sharing MM.
Promotional innovation will be the interesting challenge.
-The head scratch is already in play.
GLTA
PYC Price at posting: 6.7¢ Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

RHK

Red Hawk upgrades Blacksmith with DSO mineral resource at the Eagle Deposit

MND

Monadelphous inks $200M contract with Woodside to help build Pluto LNG – but will it make Scarborough cheaper?

TRP

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel

NVA

Nova locks in NASDAQ US market listing at a value of only US$3.3M as ASX gets quieter and quieter

MIN

MinRes jumps 5% as the company meets production guidance – depressed iron ore prices be damned

IGO

IGO kicks off earn-in copper drilling on-site Encounter's Yeneena play as it adopts new identity

Nine's staff strike as Paris Olympic coverage begins

HRZ

Horizon firms up ore reserve for Boorara ahead of FY25 Q1 development decision

ASX Market Open: ASX200 to rise for Friday session | July 26

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

There are more pages in this discussion • 42 more messages in this thread...

First 3 Last

Add PYC (ASX) to my watchlist

(20min delay)
Last 10.5¢		Change 0.000(0.00%)		Mkt cap ! $489.9M

Open	High	Low	Value	Volume
10.5¢	10.8¢	10.3¢	$174.9K	1.664M

Buyers (Bids)

No.	Vol.	Price($)
20	1219974	10.0¢

Sellers (Offers)

Price($)	Vol.	No.
10.5¢	404496	2

View Market Depth

No.	Vol.	Price($)
18	1114974	0.100
1	10101	0.099
1	5100	0.098
2	47763	0.095
1	100000	0.091

Price($)	Vol.	No.
0.105	400000	1
0.110	319862	4
0.115	635111	4
0.120	597984	4
0.125	472274	5

Last trade - 16.10pm 26/07/2024 (20 minute delay)

PYC (ASX) Chart

PYC turns 2 corners, page-3

Red Hawk upgrades Blacksmith with DSO mineral resource at the Eagle Deposit

Monadelphous inks $200M contract with Woodside to help build Pluto LNG – but will it make Scarborough cheaper?

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel

Nova locks in NASDAQ US market listing at a value of only US$3.3M as ASX gets quieter and quieter

MinRes jumps 5% as the company meets production guidance – depressed iron ore prices be damned

IGO kicks off earn-in copper drilling on-site Encounter's Yeneena play as it adopts new identity

Nine's staff strike as Paris Olympic coverage begins

Horizon firms up ore reserve for Boorara ahead of FY25 Q1 development decision

ASX Market Open: ASX200 to rise for Friday session | July 26

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

PYC turns 2 corners, page-3

Top Stories

Red Hawk upgrades Blacksmith with DSO mineral resource at the Eagle Deposit

Monadelphous inks $200M contract with Woodside to help build Pluto LNG – but will it make Scarborough cheaper?

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel

Nova locks in NASDAQ US market listing at a value of only US$3.3M as ASX gets quieter and quieter

MinRes jumps 5% as the company meets production guidance – depressed iron ore prices be damned

IGO kicks off earn-in copper drilling on-site Encounter's Yeneena play as it adopts new identity

Nine's staff strike as Paris Olympic coverage begins

Horizon firms up ore reserve for Boorara ahead of FY25 Q1 development decision

ASX Market Open: ASX200 to rise for Friday session | July 26

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News